Aptorum Group Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Nov 18, 2022--Regulatory News:Aptorum Group Limited (Nasdaq: APM, Euronext Paris: ...
Read moreNEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Nov 18, 2022--Regulatory News:Aptorum Group Limited (Nasdaq: APM, Euronext Paris: ...
Read moreIRVING, Texas--(BUSINESS WIRE)--Aug 25, 2022--biote Corp. (“Biote” or the “Company”), a high growth, differentiated medical practice-building ...
Read moreWESTLAKE VILLAGE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage ...
Read more© 2022 TheDailyStock.News